|
|
Post by Charlie on Mar 11, 2021 0:07:51 GMT -5
|
|
|
|
Post by Clement on Mar 11, 2021 7:38:14 GMT -5
nice looking ad!
|
|
|
|
Post by hellodolly on Mar 11, 2021 11:39:17 GMT -5
Thanks, very prominent "Talk to a doctor" as well as other features. I like the visual relationship with "Talk to a Doctor Online" placed next to " Save on Afrezza" as side-by-sides. Waiting on the 'but".....from our onboard "Advertising and Marketing" arm chair, keyboard warriors, official critique. |
|
|
|
Post by buyitonsale on Mar 11, 2021 16:08:22 GMT -5
It's about time "Needle-Free" is highlighted.
Most diabetics are not aware of this option.
|
|
|
|
Post by rfogel on Mar 12, 2021 9:10:38 GMT -5
Charming, but how do you get anyone to come look at it? The one thing I have noticed is that I can't find any ads anywhere on the web for afrezza. I do a single search for something like "CGMs" and subsequently practically every website I go to has ads for CGMs and diabetic related products. I search for "afrezza" and subsequently I get absolutely nothing. Why?
|
|
|
|
Post by Clement on Mar 12, 2021 9:27:04 GMT -5
Charming, but how do you get anyone to come look at it? The one thing I have noticed is that I can't find any ads anywhere on the web for afrezza. I do a single search for something like "CGMs" and subsequently practically every website I go to has ads for CGMs and diabetic related products. I search for "afrezza" and subsequently I get absolutely nothing. Why? That's incorrect. Google it. |
|
|
|
Post by cretin11 on Mar 12, 2021 10:13:36 GMT -5
Nice looking ad. As said above, getting people to see it is key.
Also, when you click “Talk to a Doctor” the disclaimer there is less than ideal, before it takes you to a third party site “not endorsed by MannKind...”
Would be so much better if instead of that, which will turn people off immediately, it took you to a VDEX doctor. MannKind would not have to issue such a stern disclaimer, as it would know that the person will get appropriate advice.
|
|
|
|
Post by Charlie on Mar 12, 2021 15:09:12 GMT -5
Nice looking ad. As said above, getting people to see it is key. Also, when you click “Talk to a Doctor” the disclaimer there is less than ideal, before it takes you to a third party site “not endorsed by MannKind...” Would be so much better if instead of that, which will turn people off immediately, it took you to a VDEX doctor. MannKind would not have to issue such a stern disclaimer, as it would know that the person will get appropriate advice. It's a Great Ad. You'd like people to think Cretin that a referral to vdex (which IS a 3rd party) would be a better reference. Do you think that a Physician from Vdex answers the call when the phone rings. Laughable. Here we are again. Mannkind comes out with a very good Ad and you and the other Vdex crowd put a cloud over the company I'm invested in. I'm not invested in Vdex. I'm invested in MNKD. I believe that the CEO and the Board are doing a great job. However, You and another Paid employee of Vdex what to ride the coattails of what looks like to be a promising Ad campaign. And yes.. Vdex adds prescriptions to MNKD's bottom line but it is Not a replacement for this company's advertising and recruitment for more scripts. Unfortunately, You make it the issue for this company and suggest it can do a better job than the Mannkind Corporation. This comes up by you and others time and time again. Vdex IS a 3rd Party. They didn't create the Ad. They are not involved in the Ad. The Credit goes to Mannkind. Seems clear enough to me no matter how much you try to cloud the issue. I have to also say that this lame argument you provide is on a Friday when Symphony Scripts are posted here. Maybe you haven't heard from Mike Castagna that the script count is NOT sourced the way it once one. The baseline has changed. All scripts are not recorded the way they once were; making the count irrelevant. If the baseline changes so does the accuracy. What we are getting every Friday is inaccurate data which can not be used to accurately calibrate increases or decreases in Script orders. Friday's #'s only give ammunition to those who want to undermine the success of the company we are invested in with effort to promote a private company Vdex; a company that has NO influence on the direction or the partnerships or the new molecules brought forth for profit by Mannkind Corporation. Friday Scripts are a distraction and no longer have merit in representing the advancement of Afrezza. Likewise, Afrezza is no longer the one trick pony. Technosphere is the Star. |
|
|
|
Post by liane on Mar 12, 2021 15:21:01 GMT -5
charlie - I'd like to remind you that all opinions are allowed here as long as done respectfully.
|
|
|
|
Post by Charlie on Mar 12, 2021 15:24:13 GMT -5
that's right Liane. And that is why I was respectful! The scripts are inaccurate. You might want to lend some credibility to what they actually mean with regard to Mikes Statement about how Scripts are reported. The Friday report does damage. It is not accurate.
|
|
|
|
Post by liane on Mar 12, 2021 15:36:31 GMT -5
The Friday scripts report may no longer be accurate, but it is all we have. I'm not going to stop tabulating the numbers, but I have no emotion attached to them.
|
|
|
|
Post by Charlie on Mar 12, 2021 15:39:25 GMT -5
The Friday scripts report may no longer be accurate, but it is all we have. I'm not going to stop tabulating the numbers, but I have no emotion attached to them. why don't you make up #'s; that would be on the same level of accuracy. The friday script report has no merit; but publish it anyway! I'm really surprise by you to stand behind a private company that tries to pressure MNKD. I don't think Alfred would agree with you; I'm sorry to say. So let's see. We acknowledge that Short Interest has an Influence on the daily share price. Investors are looking for validation to invest; Symphony Data is one target that has been used to show growth and acceptance of Afrezza. If the numbers get under-reported then the consensus becomes the topic that MNKD is failing at marketing it. Because the reported is Not reliable should it be THE FOCUS of MNKD's efforts? How does it play for short interest? Does it make the market look like it disapproves of the weekly #'s? Reason for a sell off? Or is it just the advantage given to short interest to use it as an excuse to control the market. MNKD is so played. Am I making this up? If the numbers show little growth then the assumption is that the CEO and the Board are doing a lousy job. But what if? the numbers are much higher. In any case, the numbers that are represented have little to no merit regarding Mannkind's future. You may not like what I have to say; but I'm a real investor and have been since before the reverse split. I speak for the Share Price value and about the forces that want to undermine and slow down the direction that is inevitably upward, in the face of significant opposing forces. Good Luck to Us. |
|
|
|
Post by Charlie on Mar 12, 2021 15:48:35 GMT -5
Wow! Statistics DON'T MATTER here. Who cares! We don't have anything else. Imagine Fauci saying that about the numbers that support the use of Covid Vaccine. It's this attitude that gets in the way of Science with All Due Respect.
|
|
|
|
Post by liane on Mar 12, 2021 16:06:33 GMT -5
What is reported are the Symphony script counts - nothing more - nothing less. MNKD now has other channels - but none of us have access to that info. I am accurately documenting the Symphony channel.
|
|
|
|
Post by Charlie on Mar 12, 2021 16:16:43 GMT -5
What did you think of the Newest Ad posted by Mannnkind Liane?
|
|
